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Abstract
A scheme was constructed for  synthesizing a magnetic  resonance imaging (MRI)  contrast
agent with both myeloperoxidase (MPO) sensing and superoxide dismutase (SOD) therapeutic ability.
This contrast agent was designed by modifying a previously published paramagnetic SOD mimetic
with  therapeutic  ability  to  contain  a substrate group for  MPO.  This  allows the contrast  agent  to
accumulate in sites of high MPO concentration, increasing MRI signal intensity.
The scheme relies on economic dipicolinic acid as a starting material for the functionalized
ligand.  The reaction intended to be utilized to attach the MPO substrate is an environmentally-friendly
“click  chemistry”  reaction.   Both  synthetic  building  blocks  for  the  click  chemistry  reaction  were
synthesized and characterized and a new, final scheme was devised in order to increase yield and
convenience.
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Introduction
Contrast  agents  in  Magnetic  Resonance  Imaging  (MRI)  are  important  tools  in  medical
diagnostics; they are used to enhance the image or highlight specific areas in the body.   MRI can
generate high resolution images of complex anatomical structures.  Differences in signal intensity are
visualized as contrast, which causes some areas to appear highlighted.  Some pathological conditions
cause a measurable change in the local signal intensity, however many do not[1].   Contrast agents
interact with water molecules to alter the signal intensity in the local area.   Some contrast agents,
known as sensing contrast agents (SCAs), also interact with specific biological markers that can be
monitored to track the progression of various diseases.  This allows MR images to show the presence
of these molecules of interest that would normally blend in with the background because they either
lack the ability to alter  water relaxation times (i.e.  non-para- or superparamagnetic)  or lack highly
mobile protons that can be detected by chemical saturation-transfer techniques (CEST)[2].
Myeloperoxidse (MPO) is an enzyme of interest that plays a critical role in inflammation.  MPO
is  found  in  the  azurophilic  granules  of  neutrophils,  which  are  the  most  abundant  leukocytes  in
humans[3].  Its total activity in humans is therefore very high and the presence of MPO in vascular
lesions  and  in  circulation  has  been  shown  to  correlate  with  the  outcome  of  stroke  and  other
cardiovascular disease[4].  When released as a result of the activation and subsequent degranulation
of neutrophils, MPO reacts with endogenous H2O2 and chloride ions or aromatic alcohol residues to
produce highly  reactive molecular  species such as hypochlorite  ions and tyrosyl  radicals  (though
tyrosine is much less active as  MPO reducing molecule than 5-hydroxytryptamine (serotonin)).  These
reactive molecular species can go on to stimulate cellular inflammatory signaling cascades.  Imaging
of MPO activity has been achieved by substituting one or more hydroxyindole groups onto a ligand
that can then be chelated to a paramagnetic metal center.  The radicals that form when these contrast
agents interact with MPO go on to interact with proteins or other molecules of contrast agent, leading
to cross-linking and oligomerization, respectively[5].  Both of these processes lead to a change in the
signal from water molecules in the local environment.  
One source of H2O2 is the dismutation of the superoxide anion (O2-,  which is usually produced
by NAPH oxidase of phagocytes and endothelial cells)  by superoxide dismutase (SOD).  Superoxide
is a free radical produced as a byproduct of normal respiration in the mitochondria.  In mice, Mn-SOD
deficiency has been shown to exacerbate cerebral infarction following ischemia, which suggests that
excess superoxide plays a key role[6]. A family of paramagnetic manganese macrocycles has been
shown to mimic SOD activity without producing measurable toxic effects.   One of such compounds,
M40401, has a catalytic rate exceeding that of the native enzyme[7].  M40401 can be potentially used
in MRI to enhance signal in ischemic areas of the brain because the Mn center of this SOD mimetic is
a paramagnetic metal cation. 
Dr. Bogdanov’s laboratory of Molecular Imaging Probes at UMASS Medical School has been
working toward synthesizing a functionalized paramagnetic SOD mimetic that also acts as a substrate
for MPO (2).  This compound can be potentially used to detect the activity of MPO in vivo using MRI
because: 1) it is paramagnetic and therefore detectable by MRI; 2) it reacts with the superoxide anion
to produce hydrogen peroxide, which is the primary substrate of MPO; 3) it carries a reducing moiety
that converts oxidized MPO into a reactive state during every enzymatic cycle.  
Background
The goals  of  this  project  were  to  synthesize  2 and  examine  the  kinetic  properties  of  the
compound in vitro.   The synthetic strategy will be accomplished in the future by converting one of the
ligands to an azide and using the Cu(I) catalyzed Alkyne-Azide 4+2 cycloaddition to join the ligand
onto the 5-hydroxyindole (5-HT) group.  
Figure 1 Scheme for functionalization of ligand
This reaction falls into the category of “click chemistry”, a subset of reactions with many favorable
characteristics  which  include  high  yield,  mild  conditions,  and  little  to  no  purification[8].   The  final
macrocyclic product bearing a reducing 5-HT moiety  has not yet been tested in this project. However,
a synthetic strategy has been developed that yielded a precursor building block carrying the reactive
azide  that will be used for further condensation reaction yielding the final product.
Figure 2 Scheme for synthesis of azide
MRI
MR Images are generated by exposing samples to an external magnetic  field,  B0,  and an
induced magnetic field, B1.   When a sample is placed in the B0 field, some nuclei interact with the field
and orient  themselves in discrete directions relative to the  B0 field.   This is because those atoms
possess a quantum mechanical property called nuclear spin, given by the quantum number I.  Nuclear
spin is a consequence of the individual protons and neutrons in the nucleus rotating along an axis, and
can be visualized as a vector, I, parallel to the axis of rotation of the nucleus as a whole.  The formula
for I is given thus:
∣I∣=hI ( I+1)
2
The quantum mechanical energy levels, mI, are restricted to 2I + 1 discrete values (-I , -I + 1, …, I),
each corresponding to an I vector with a different orientation relative to the B0 field.  Because protons
are positively charged, spinning protons in the nucleus generate a dipolar magnetic moment vector, µ,
that is parallel to the I vector.  The magnitude of µ is proportional to the value of I based on a constant
called the gyromagnetic ratio, γ, which is unique for each isotope.  Transitions between nuclear energy
levels are  dependent on  γ, and excitation of a sample occurs when a rotating  B1 field is generated
perpendicular to the  B0 field by RF pulses of a certain frequency (called the Larmor frequency, a
constant proportional to γ).  
1H  nuclei,  commonly  referred  to  as  protons,  have  a  spin  number  of  ½  and  are  almost
exclusively the target used to generate a signal in MRI.  Nuclei with a spin number of ½ are restricted
to two quantum mechanical spin states (mI = ½ and mI = -½).  The sum of all the magnetic moment
vectors in a sample of protons gives rise to a macroscopic magnetization vector,  M.   The B0 field is
conventionally oriented along the z-axis if a coordinate plane is assigned to the sample space.  In an
unexcited sample, the x and y components of u are randomly distributed around the B0 field, meaning
the x and y components of M are zero.  The z component of M, however, is proportional to the B0 field,
resting  at  an equilibrium when a sample  is  in  the ground state.   When a sample  is  excited,  the
transition to a higher energy state raises the value of Mz , and the rotating B1 field pulls M off the z axis
and into the x,y plane.  When the B1 field is turned off, M will still have some non-zero component in
the x,y-plane, causing it to rotate around the B0 field[9].  
There are two main reference parameters in MRI.  Both rely on the concept of relaxation, or the
return of the components of  M to their equilibrium values.   The return of  Mz to its equilibrium value,
called spin-lattice relaxation, depends on the transition of excited nuclei back to their ground state and
is characterized by a time constant,  T1.   Processes that generate large amounts of magnetic noise,
such as electronic dipole interactions, can stimulate an excited nucleus to return to ground state faster
and lower  the  T1 value.   Spin-spin relaxation,  or  T2 relaxation,  is  the process where the  x and  y
components of M decay to zero.  This is generally caused by interference from the random motion of
the molecules in a sample[1].  T1 values vary more depending on the sample, but T2 values are lower
than  T1.   There is a third parameter that can be used to affect images in MRI called  ρ,  or proton
density, but this value is not affected by contrast agents and thus not of interest in this study.
Spatial information is recorded by using a gradient B1 field.  With the gradient applied, only a
specific slice of the B1 field has the correct energy to excite a sample.  Signal intensity, generated from
the relaxation and proton density values, is plotted against the spatial information to generate a two or
three dimensional image.
Contrast Agents
Radionuclide-based imaging methods such as positron emission tomography (PET) and single
photon  emission  computed tomography (SPECT)  rely  on  radioactive  contrast  agents  to  generate
signals.  These methods often require scans from multiple imaging types in order to generate a higher
resolution background image around signals from specific interactions.   MRI has the advantage of
generating  a  high  resolution  background  image  as  well  as  highlighting  specific  biochemical
interactions.   Contrast agents in MRI work by reducing the relaxation times of surrounding protons.
 This allows for a shorter time between RF pulses without saturating the signal, leading to a higher
resolution image[9].  Relaxivity (R) values are used to describe the efficacy of a contrast agent and are
inversely proportional to T1 and T2 values.  Highly paramagnetic contrast agents more strongly affect
the T1 values while Fe3O4 based contrast agents are T2 based[1].  Gd(III) and Mn(II), with seven and
five unpaired electrons, respectively,  are the most commonly used species for  T1 contrast agents.
 This study focuses on T1 contrast agents so those based on Fe3O4 will not be discussed.
The R1 value of a T1 contrast agent is based on two types of interactions, inner sphere (IS) and
outer sphere (OS).  IS interactions focus on the water molecules (usually 1 or 2) directly coordinated
to the metal center of the contrast agent.   These molecules are aligned in a specific orientation and
can interact with other nearby water molecules, which accounts for the OS interactions.  
Figure 3 Contrast Agent interactions
The exchange rate of coordinated water molecules, τm, reflects the amount of time a molecule stays
bound to the metal center, while the reorientation time, τr, expresses how much the complex tumbles
in solution.  An increase in τr or a decrease in τm will lead to a higher R1 value[10].  
Smart  or  sensing contrast  agents (SCAs)  respond to a biological  stimulus that  leads to a
measurable change in relaxivity.   This can be a general stimulus such as a change in pH or a more
specific  mechanism  such  as  an  enzymatic  reaction[11].   SCAs  that  respond  to  general  stimuli
(environmental SCAs) can detect a variety of different changes.   One way to generate a change in
relaxivity is  to  create an SCA where the exposure of  the metal  center  to  the  bulk  water  can be
changed.   This has been accomplished in  the past  by attaching Gd-chelating groups that  change
affinity when protonated or have a higher affinity for other metals such as Ca or Zn[12][13].   This
allows changes in pH or ion concentration to be seen in vivo as a change in MRI signal intensity.
Enzyme-sensing  SCAs  are  especially  promising  because  specific  enzymes  can  be  used  as
biomarkers for a variety of diseases.   Early enzymatic SCAs focused on utilizing enzymes’ ability to
cleave chemical bonds[14].  Enzymes such as phosphatases, hydrolases, and peptidases all cleave a
specific type of chemical bond.  Functional groups that can compete with water for free chelating spots
on the metal center can be attached to the ligand and cleaved off by these specific enzymes.   This
allows for a large increase in relaxivity by exposing more water molecules to the electronic effects of
the metal center.  Another method for detecting enzymatic activity in MRI is to design SCAs that are
susceptible to enzymatic oxidation and/or polymerization.  Many enzymes do not catalyze cleavage of
a specific bond, but instead convert the substrate into a more reactive intermediate which can form
new bonds without further catalysis.   Contrast agents attached to substrates for such enzymes can
show a significant change in relaxivity after catalysis and subsequent reactions[15].   One reason for
this is that bulkier products such as oligomers and proteins bound to contrast agent have a much
larger τr.  Bulkier products often remain in the body for a longer period of time, resulting in a retention
of the local increase in signal intensity.   This provides a way to check for the presence of specific
enzymes in different areas of the body.
MPO
Myleoperoxidase (MPO) is  a protein released from neutrophils during a process known as
degranulation.  Degranulation happens during phagocytosis when granules in the neutrophils release
their contents into the phagosome.  The products of degranulation can also escape the phagocyte and
go on to cause damage to normal cell  tissue.   Reactive species generated by MPO are normally
responsible for killing invasive species in the body,  meaning they have the potential to cause some
pathological conditions[16].   Accumulation of  MPO can cause  serious complications, especially with
atherosclerosis,  a  heart  disease caused by accumulation  of  plaque on the inside of  the  arteries.
 Numerous studies have shown that elevated levels of MPO correlate to adverse effects brought on by
atherosclerosis[4][17][18].   One possible explanation  for  this  is  an attack on the more pathogenic
plaque by neutrophils.   This would cause a release of MPO that could cause oxidative damage and
trigger  more  adverse  effects  from  the  arterial  plaque.   The  products  created  by  MPO  can  also
stimulate inflammation pathways.  The benefits of detecting MPO have clear benefits in diagnostic and
preventative medicine.
In  order  to  detect  MPO,  it  is  necessary  to  understand  the  mechanism  of  the  enzymatic
reaction.  The active site of MPO consists of a heme group with a coordinated metal ion, Fe(III).  This
ion is oxidized by a molecule of H2O2 to generate a free radical Fe(IV) intermediate (MPO-I)[19].  To
regenerate the active  site,  this  intermediate can react  with a Cl- ion to generate the much more
reactive ClO- ion or it can react with two tyrosine residues to create free radicals that can cause cross-
linking of proteins[20].  
Figure 4 MPO mechanism
MPO-I  can also  react  with  other  aromatic  alcohol  (AOH)  groups  such  as  5-hydroxytryptophan  to
generate reactive species that can oligomerize or also cause cross-linking[21].  
Figure 5 Oligomerization
Figure 6 Cross-Linking
Kinetic studies have  also  shown that molecules containing 5-hydroxytryptamide (5-HT) groups can
outcompete chloride anions as a substrate for MPO[22].
Detection of MPO has traditionally been achieved by running in vitro tests on cell  samples
samples taken from patients[4].  Monitoring MPO with MRI has potential for faster and more specific
detection.   Contrast  agents  have  been  synthesized  that  can  accumulate  in  sites  with  high
concentrations of MPO[23].   The products  that  form  when this contrast agent is oxidized by MPO
accumulate in tissue samples much longer than the free contrast agent, leading to an increase in
signal intensity for several days.  These contrast agents are synthesized by chemically modifying the
ligand around the Gd(III) center to contain one or more A-OH groups[24].  
SOD
Superoxide (O2-) is a reactive oxygen species possessing an unpaired electron.  It is produced
as a byproduct of normal cellular respiration in the mitochondria and also generated by neutrophils to
aid in the phagocytosis process[25]. This free-radical can cause significant oxidative damage when it
is  present  in excess.   Excess O2- is  present  in the same situations where excess neutrophils are
present, such as inflamed or ischemic regions of tissue or in patients suffering from an autoimmune
disorder. O2- decays naturally into hydrogen peroxide and molecular oxygen, but this does not happen
fast enough to prevent damage[26].  Superoxide dismutase (SOD) is an essential enzyme present in
multiple areas of the cell  in different forms.   Mn-SOD is present in the mitochondria while various
Cu/Zn-SODs  are  present  outside  the  mitochondria  both  in  plasma  and  extracellularly.   SOD
deficiencies have been shown to play a critical role in ALS and many other diseases[27].
The evident importance of superoxide as a target for therapeutic agents has sparked decades
of research into low molecular weight mimetics for SOD.   Low molecular weight agents with SOD
activity are able to diffuse into intracellular space and potentially permeate cell membranes better than
the native enzyme.  They also have the potential to have a much higher half life in the blood than the
native enzyme (t1/2  ≈  minutes).   Rational  design of  pharmaceutical  agents also allows chemists to
design a drug that will have a higher affinity for either an aqueous or lipid medium, allowing for more
selective delivery depending on the composition of the area with an overproduction of O2-[7].  Ions of
Cu, Fe, and Mn have been shown to posses SOD mimetic activity.  Early reports of metal complexes
with SOD mimetic activity mainly focused on Cu complexes.   Iron SOD mimetics have also been
developed  but  the  toxicity  of  both  free  metal  ions  limits  the  pharmaceutical  potential  of  such
complexes.  Manganese complexes have a much higher therapeutic potential because of the reduced
toxicity of  free Mn ions  compared to other  candidates[27].   Manganese complexes also  have the
advantage of being paramagnetic, meaning their distribution can be monitored by MRI.  Mn(II) has five
unpaired d electrons, making its complexes excellent candidates for T1 contrast agents.  
In order to design more efficient SOD mimetics, an understanding of the mechanism of metal-
induced superoxide dismutation is required.   Studies have shown that the rate determining step in
Mn(II)-mediated O2- dismutation is the oxidation of Mn(II) to Mn(III).  This means that higher catalytic
rates can be achieved by designing a Mn(II) complex whose geometry closely resembles the favored
geometry of the corresponding Mn(III) complex.   One research group has used computer modeling
programs  to  find  such  a  complex,  M40401,  off  of  the  parent  complex  M40403[7].   The  S,S-
stereochemistry  of  M40401 holds  it  in  a  geometry  that  resembles  the  favored  pseudooctahedral
geometry of the oxidized Mn(III) form.   M40401 has been shown to have a catalytic rate that is two
orders of magnitude greater than the parent complex, and even exceeds the rate of the native Mn-
SOD enzyme.   The  R,R-stereoisomer of M40401 is constrained to a much different geometry that
does not favor the folding associated with oxidation.   Because of this, the R,R-isomer is catalytically
inactive.
The family of SOD mimetics containing coordinated manganese cations belong to a family of
theranostic agents. Theranostics is usually understood as a combination of the diagnostic study and
therapeutic application of the same compound.  It involves imaging chemical agents in order to deliver
appropriate  therapies  based on specific  chemical  interactions  and a  generation  of  specific  signal
detectable by imaging instruments.  In this regard,  M40401 ideally fits into this category as a contrast
agent and an SOD mimetic, i.e. a compound with a theranostic potential.  The initial tests that involved
injection of M40401 encapsulated into liposomes into mice showed signal enhancement in the brain
for at least 4 days post injection.  MRI has shown that the enhancement of T1-weighted images (i.e.
enhanced as a result of Mn(II) presence) returned to the background levels after 9 days in the cortical,
subcortical,  and  hippocampal  regions,  suggesting  that  liposomes  carrying  M40401  release  this
compound and that it transiently accumulates in the neural tissue and is slow to be cleared away.
Therefore, M40401 was clearly visible in vivo using a 3T clinical MR magnet[28]. 
We envision combining M40401 with an MPO-sensing substrate that will result in a theranostic
agent. This agent will enable the use of MRI for determining regions of ongoing inflammation in the
vascular wall. This is feasible because MRI has a very high anatomical resolution and can utilize a
variety of imaging sequences to tell the flowing blood from the blood vessel wall (which will appear
stationary and enhanced if this new theranostic compound is present). The detection of inflamed areas
in blood vessels is very important for assessing which areas could potentially trigger vascular wall
instability,  rupture,  and potential  formation of  a blood clot.  At  the same time,  the Mn(II)  center in
M40401 (that will  stay immobilized in the vascular wall due to MPO activation and MPO-mediated
binding to the cellular and extracellular components) will function as a SOD mimetic, decreasing the
local damaging concentration of superoxide radicals and helping to temporarily alleviate the ongoing
inflammation.
Click Chemistry
“Click chemistry”  is  a term used to describe an attractive new field of  research.   It  entails
generating a series of molecular building blocks that react easily and reliably.  A review published by
the Sharpless research group defines the following set of criteria for a click reaction: 1) modular; 2)
wide  in  scope;  3)  very  high  yields;  4)  generates  inoffensive  byproducts;  5)  stereospecific  (not
necessarily  enantiomerically  selective);  6)  simple  reaction  conditions;  7)  readily  available  starting
materials; 8) no solvent or use of a benign solvent (such as water or alcohol); and 9) simple product
isolation (no need for preparative chromatography)[8].   By focusing synthetic strategies on reactions
that  fit  these  criteria,  chemists  can  greatly  reduce  the  cost  and  environmental  impact  of  their
syntheses.  
One reaction that fits the criteria of click chemistry is the Cu(I) catalyzed Huisgen dipolar-1,3-
cycloaddition  of  azides  and  alkynes.   This  reaction  produces  1,3-substituted  triazoles  linking  two
molecules using two functional groups that are easy to introduce.   Azides are generally synthesized
from alkyl  halides in  high yields via nucleophilic  substitution reactions.   Alkynes bearing amino or
alcohol groups can also be purchased from most commercial vendors and linked onto another building
block.  
Methodology
All reagents were purchased from Sigma-Aldrich, Strem Chemicals, Fisher scientific, or VWR
and used as received unless indicated.   Dichloromethane and pyridine were dried and distilled over
CaH2 and KOH respectively.  Reactions were performed in open air unless otherwise specified.  TLC
analysis was performed on silica gel plates or Reverse Phase-C18 plates.   The stationary phase for
column chromatography was  60-240 mesh activated silica gel.  NMR spectra were recorded on a
400mHz machine.  Melting point analysis was taken on a standard MelTemp apparatus. 
2,6-dipicolinic acid N-oxide
A suspension of 2,6-dipicolinic acid, 1a, (15.05g, 0.090 mol) was prepared in 30% H2O2 (52.5
ml) and cooled to 0  oC in an ice bath.   Na2WO4 (0.14g, 0.54 mmol, 0.6 mol-%) was added in one
portion and the suspension was heated to 100 oC for 2h with stirring.  The suspension was cooled to
room temperature and a second portion of  H2O2 was added (105 ml).   The reaction mixture was
heated at 100 oC overnight.  During this time the white solids dissolved to indicate product formation.
 The reaction mixture was cooled to 0  oC to precipitate the product which was isolated by vacuum
filtration and washed with ice water (2 x 10 ml).  The filtrate was extracted with CH2Cl2 (3 x 50 ml) and
combined  organic  extracts  were  dried  over  Na2SO4,  filtered,  and  concentrated  under  reduced
pressure.   Product crops were combined, recrystallized from hot H2O and dried by lyophilization to
yield 9.18g (56%) of dipicolinic acid-N-oxide, 1b.  Mp: 160-162 oC.
4-chloro-2,6-pyridinedicarbonyl dichloride
N-oxide 1b (9.18g, 0.050 mol) was suspended in freshly distilled CH2Cl2 (100 ml) and cooled to
-10 oC by suspending over liquid N2.   The suspension was purged with Ar and oxalyl chloride (42.88
ml, 0.50 mol) was added dropwise with vigorous stirring.  The reaction mixture was stirred for 10 min
then 2 drops of anhydrous DMF were added and a fizzing sound was observed.  The reaction mixture
was allowed to warm to room temperature after 8h and then stirred under Ar for an additional 3 days.
 Solvent and oxalyl chloride were carefully removed under reduced pressure to yield crude 4-chloro-
2,6-pyridinedicarbonyl dichloride,  2a  (12.32g).   The product was dried in vacuum and used without
further purification.  
Meldrum's Intermediate
Meldrum’s acid (4.61g, 0.032 mol) was dissolved in distilled CH2Cl2 (20 ml) and cooled in a
salt/ice bath.  Freshly distilled pyridine (5.16 ml, 0.064 mol) was added and the solution was purged
with Ar.   Acid chloride  2a (3.83g*, 0.016 mol) was dissolved in distilled CH2Cl2 and added dropwise
with  stirring.   The  reaction  mixture  was  stirred  for  1h  in  the  salt/ice  bath  then  warmed  to  room
temperature and stirred for an additional 1h.  The brown solution was washed with 2N HCl (2 x 25 ml)
then water (4 x 25 ml), dried over Na2SO4, filtered, and concentrated under reduced pressure to yield
Meldrum’s adduct 2b.  The product was used in the next reaction without further purification.
4-chloro-2,6-diacetylpyridine
Meldrum’s condensation product 2b (0.016 mol calcd. from previous reaction) was refluxed in
H2O/glacial acetic acid (100 ml,  2:1) for 5h until  product formation stopped on TLC.   The reaction
mixture was extracted with CH2Cl2 (4 x 100 ml) and the organic phase was filtered then washed with
5% aqueous NaHCO3 (2 x 100 ml) and H2O (2 x 50 ml).  The organic phase was dried over Na2SO4,
filtered, and concentrated to yield a brown crude product.   The crude product was purified via flash
chromatography on activated silica (0 - 10% EtOAc in Hexane) to yield pure 4-chlorodiacetylpyridine,
3 (0.45g, 14% over 2 steps). 
4-azido-2,6-diacetylpyridine
Aryl chloride 3 (0.88g, 4.4mmol) was dissolved in anhydrous DMF.  Oxygen was removed by
three cycles under high vacuum and replaced with Ar.   NaN3 (2.86g, 44 mmol) was added in one
portion and the bright yellow solution was heated at 50  oC overnight under a slow stream of Ar.   A
white solid (NaCl) had fallen out of solution the next day.   The reaction mixture was cooled to room
temperature and poured into cold water (35 ml) to precipitate a yellow solid.  The solid was examined
on TLC (EtOAc/Hexane, 1:1) to reveal the starting material 3 as the major component and a smaller
presence  of  a  new  product  suspected  to  be  the  azide,  4.   The  solid  was  purified  by  flash
chromatography. 1H NMR (400 MHz, CDCl3) δ (ppm): 7.83 (2H, s) 2.80 (6H, s).  13C NMR (100 MHz,
CDCl3) δ (ppm): 26 (s), 115 (s), 154.5 (s), 197 (s).
2-(2-propiolamidoethyl)-1H-indol-5-yl benzoate
Amine 7b (0.27g, 1 mmol) was dissolved in anhydrous DMF (3 ml) and propiolic acid (0.093
ml, 1.5 mmol) was added in one portion.  HBTU (0.569g, 1.5mmol) was suspended in DMF (1 ml) and
added slowly.  DIEA (0.435 ml, 2.5 mmol) was added and the reaction mixture turned pale yellow.  The
mixture was stirred at room temperature for one hour and examined on TLC (EtOAc/Hexane, 1:1)
which showed consumption of starting material propiolic acid.   The reaction mixture was partitioned
between EtOAc (150 ml) and 1N HCl (150 ml) and the organic phase was washed with 1N HCl (2 x 50
ml), sat. NaHCO3 (2 x 50 ml), and brine (2 x 40 ml).   The organic portion was dried over Na2SO4,
filtered and concentrated under reduced pressure to yield a golden brown oil.  The crude product was
purified via flash chromatography on activated silica (10 - 67% EtOAc in Hexane) to yield amide  8
(0.26g, 82%) as a yellow oil.   The product was analyzed by NMR spectroscopy.1H NMR (400 MHz,
CDCl3) δ (ppm): 2.73 (1H, s), 2.95 (2H, t), 3.61 (2H, q), 5.11 (1H, s), 7.32 (9H, m), 8.18 (1H, s).
2-((2-(1-(2,6-diacetylpyridin-4-yl)-1H-1,2,3-triazol-4-yl)ethyl)carbamoyl)-1H-
indol-5-yl benzoate
Alkyne  8 (0.22g,  0.68mmol)  was dissolved in  CH3CN (2 ml)  and  4 (0.14g,  0.68mmol)  was
added in one portion.   The solution was purged with Ar and purified CuI  (0.02g,  0.068mmol)  was
added.   The reaction mixture was stirred for 3h at  room temperature under a cushion of Ar.   The
reaction was diluted in EtOAc (50 ml) and washed with sat. aqueous NH4Cl/NH4OH (1:1, 2 x 30 ml).
 The organic phase was dried over Na2SO4, filtered, and concentrated under reduced pressure to yield
an orange solid.  Analysis on the solid was inconclusive.
2-(5-(benzoyloxy)-1H-indol-2-yl)acetic acid
Nitrile  7a (2.05g,  7.8  mmol)  was  suspended  in  20% aqueous  KOH (20  ml)  and  refluxed
overnight.   The next day, all reagents had dissolved to produce a brown solution.  Concentrated HCl
(10N, ~8 ml) was slowly added with stirring until the solution was neutral to precipitate the product as
a pinkish solid.  The solid was stored under Ar at 4 °C for further analysis.
Discussion
The  initial  component  of  our  synthetic  scheme required  the  search  for  a  convenient  and
inexpensive approach to the synthesis of the initial precursor: 4-chloropyridine dicarbonyl dichloride.
The synthesis of this precursor was commonly achieved in the past by chlorination of commercially
available chelidamic acid[29][30].  
Figure 7 Traditional starting material and functionalization method
The high cost of this reagent made this method undesirable, so an alternative synthesis was sought.  
A  recent  publication  describes  a  synthesis  of  4-chloropyridine  dicarbonyl  dichloride  from
inexpensive dipicolinic acid[31].   Conversion of the dipicolinic acid into an n-oxide activates the para
position  of  the  pyridine  ring  toward  electrophilic  substitution.   Treatment  of  the  n-oxide  with  10
equivalents of  oxalyl  chloride over three days resulted in a high yield conversion into the desired
product.  It must be noted that the diacid dichloride is moisture sensitive and should be reacted in the
next step as soon as possible.   Oxalyl chloride is an extremely corrosive reagent and great caution
must be taken when removing excess from the reaction mixture.
The  two-step  conversion  of  4-chloropyridine  dicarbonyl  dichloride  into  4-chloro-2,6-
diacetylpyridine  with  Meldrum’s  acid  did  not  proceed  exactly  as  described  in  the  literature[32].
 Extraction and isolation of product in both steps proved to be exceedingly difficult and the yields for
these steps were lower than those previously reported.   The reported yields for this reaction were
already low (~33%), so alternatives were sought from the beginning.  The Gilman reagent, (CH3)2CuLi,
was examined as an alternative, but the limited solubility of the acid chloride in THF or Et2O at the low
temperatures required for the reaction resulted in low yields.  Following a literature recommendation,
an attempt was made to increase the yield of the initial two-step process.  The commercially available
Meldrum’s acid was recrystallized before use and the pyridine and dichloromethane were distilled.
 The effect of the purified reagents was not established because of problems during extractions were
encountered that may have lowered the yield.  Hydrolysis of the acid chloride was suspected to be a
negative factor affecting the reaction yield, which is why the trichloride should be reacted as soon as
possible.  
Figure 8 Hydrolysis
The sub-optimal extraction conditions that are recommended in the literature for isolating the products
in both steps contributed to the undesirable lower yield as well.  A plausible alternative to this reaction
has been identified that also uses a two step process.  A recent paper[35] describes a conversion of
para-substituted dicarbonylpyridine dichlorides into diketones by first converting the acid chloride into
a secondary amide and then treating the amide with commercially available MeMgCl.  
Figure 9 New ketone synthesis
This reaction will  be attempted in the future in order to avoid all the problems associated with the
meldrum’s reaction.
Conversion  of  4-chloro-2,6-diacetylpyridine  into  the  respective  azide  was  accomplished
following  a  synthesis  designed  for  the  2,6-diester  derivative[33].   Yields  were  lower  than  those
reported in the literature and the product was contaminated with starting material.  The para-chloride
group on the diester is suspected to be more reactive toward nucleophilic substitution than in the
diketone, which would mean more vigorous reaction conditions are required for complete conversion
of the diketone.  In the future, temperature will be increased and the reaction will be monitored by TLC
until complete consumption of the starting material is observed.  Another problem with this synthesis
was  the  formation  of  condensation  by-products,  indicated  by  a  red-orange  color  in  the  reaction
mixture.  Eliminating oxygen from the reaction mixture in the future will hopefully reduce the formation
of by-products in the more vigorous conditions than need to be employed.  
Dr. Bogdanov’s laboratory has done research in the past with contrast agents containing 5-
hydroxytryptamine  groups,  so  there  was  a  readily  available  supply  of  benzyl-protected  5-
hydroxytryptamine.  This indole amine was conjugated with commercially available propiolic acid using
HBTU as a coupling reagent.  This reaction produced a gold colored oil that turned brown if exposed
to light or air  for too long.   The high sensitivity of this compound made it  difficult  to isolate.   The
literature also has few examples of propiolic acid derivative being used for Cu(I) cycloadditions.  The
conjugation of the carbonyl carbon with the triple bond is suspected to be a factor.   A new alkyne,
propargylamine,  was  proposed  for  the  Cu(I)  cycloaddition  which  would  eliminate  the  problems
previously encountered with isolation of the alkyne and lead to a product with a free amino group.
 This product can then be conjugated to an indole acetic acid that can be synthesized in good yields in
one step from the corresponding nitrile.
The click chemistry intermediates, 4-azido-2,6-diacetylpyridine and 2-(2-propiolamidoethyl)-1H-
indol-5-yl benzoate, were synthesized and characterized by NMR spectroscopy.  
Figure 10 Click chemistry reagents
These reagents were mixed with a Cu(I) catalyst in acetonitrile, but the reaction proceeded very slowly
as monitored by TLC.   Analysis on this reaction mixture was inconclusive, and a literature analysis
showed that some research groups were having similar problems with heterocycles as click chemistry
intermediates[34].   Extra lone pairs of electrons, such as the lone pair on the pyridine nitrogen, can
coordinate and scavenge free copper  catalyst.   This  results in  longer  reaction times and reduced
yields.  One way of solving this problem is to use a Cu(I) catalyst bound to a ligand to eliminate the
possibility of the heterocycle coordinating to free catalyst.  A new scheme has been devised that uses
a ligand-bound Cu(I)  catalyst  and replaces the 2-(2-propiolamidoethyl)-1H-indol-5-yl  benzoate with
propargylamine.   The indole  substrate will  be  linked via  a peptide  bond after  the Cu(I)  catalyzed
cycloaddition.  
Figure 11 Click chemistry scheme
This new scheme will hopefully result in higher yields and shorter reaction times.  
The  catalyst  for  the  cycloaddition  will  be  synthesized  in  two  steps  from  Cu2O  and  two
commercially available ligands.  
Figure 12 Ligands 4,7-dichloro-1,10-phenanthroline and SIMes Hcl
An attempt was made to synthesize the first  step of  this catalyst  with the N-heterocyclic carbene
ligand, 1,3-bis(2,4,6-trimethylphenyl)imidazolinium chloride.  During the synthesis we encountered the
problems  with  the  resultant  product  crystallization.   Deviations  from  the  literature  procedure  are
suspected to be the cause, and the procedure will be repeated more carefully this summer.  
The  synthesis  of  the  end  product,  i.e.  a  Mn(II)  coordinating  macrocycle  will  proceed  as
described previously in the literature for M40401 using the 5-HT functionalized ligand in place of 2,6-
diacetylpyridine[7].   This synthesis is a two-step procedure that  involves refluxing the ligands with
ultra-pure MnCl2 in anhydrous ethanol then reducing the double bonds that form with a heterogeneous
Pd/C and NH4COH system in anhydrous methanol.  The heterogeneous reduction is essential in order
to form a product with the correct stereochemistry.   Using a homogeneous catalyst system, such as
NaBH4, for reduction produces the catalytically inactive R,R-stereoisomer.  The reduction with Pd/C is
also expected to be a convenient approach for removing the benzyl protecting group from the indole
substituent.  
Figure 13 Macrocycle scheme
Conclusion
A plausible scheme has been devised for synthesizing a theranostic MRI contrast agent that
possesses both superoxide dismutase activity and the ability to detect myeloperoxidase.  This scheme
relies on readily available starting materials and utilizes the environmentally friendly and economical
click chemistry reaction, the Cu(I) catalyzed Huisgen dipolar-1,3-cycloaddition of azides and alkynes.
The following was concluded during the course of the project in order to improve the initial
scheme:  1)  Dipicolinic  acid  is  an  economical,  commercially  available  starting  material.  2)  The
Meldrum's acid synthesis is both inconvenient and low-yielding, but can be replaced with a 2-step
amide/Grignard  Reagent  reaction.  3)  Condensation  product  formation  must  be  monitored  and
prevented during the ketone synthesis. 4) Heterocyclic reactants posses low reactivity toward free
copper catalyst due to scavanging of Cu(I) by lone pairs or electrons. 5) The conjugated product of
propiolic acid and the indole substrate demonstrated low reactivity in the click reaction, and 6) Starting
materials for a new, more reactive scheme can be synthesized from readily available reagents.
Figure 14 Total scheme
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Appendix: NMR Spectra
Figure 15 1H NMR Spectrum of 4-azido-2,6-diacetylpyridine
Figure 16 13C NMR Spectrum of 4-azido-2,6-diacetylpyridine
Figure 17 1H NMR Spectrum of 5-Bz-Serotonin
Figure 18 13C NMR Spectrum of 5-Bz-Serotonin
Figure 19 1H NMR Spectrum of 2-(2-propiolamidoethyl)-1H-indol-5-yl benzoate
Figure 20 13C NMR Spectrum of 2-(2-propiolamidoethyl)-1H-indol-5-yl benzoate
